Establishing a high iron model and observing indexes related to iron metabolism in mice

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 8, 2007, Pages 1593-1597

  Zhu, Hang ^a   Luo, Hai Ji ^a   Deng, Hong ^a   Lei, Lei ^a   Zhang, Shou Hua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; IRON DEXTRAN; MALONALDEHYDE; SODIUM CHLORIDE; STAINLESS STEEL; SUPEROXIDE DISMUTASE; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BODY MASS; BODY WEIGHT; CAGE; CELL DAMAGE; CELL DEGENERATION; CELL FUNCTION; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FEMALE; FLUID INTAKE; FOOD COMPOSITION; FOOD INTAKE; HEART; HISTOPATHOLOGY; IN VIVO STUDY; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; KIDNEY PARENCHYMA; LIVER LEVEL; LUNG PARENCHYMA; MALE; MICROSCOPY; MOUSE; NONHUMAN; NUTRITIONAL STATUS; SPLEEN; TISSUE INJURY;

EID: 34250320122     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Corradini E, Ferrara F, Poetrangelo A. Iron and the liver. Pediatr Endocrinol Rev 2004;2 Suppl 2:245-248
2. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 2001;154(3):193-206
3. Feder JN, Gnirke A, Thomas W, et al.The discovery of the new haemochromatosis gene. 1996. J Hepatol 2003;38(6):704-709
4. Sengolge G, Horl WH, Sunder-Plassmann G. Intravenous iron therapy: well-tolerated,yet not harmless. Eur J Clin Invest 2005;35 Suppl 3:46-51
5. Siah CW, Ombiga J, Adams LA, et al. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev 2006;27(1):5-16
6. Afanas'ev IB. Superoxide and nitric oxide in pathological conditions associated with iron overload: the effects of antioxidants and chelators. Curr Med Chem 2005;12(23):2731-2739
7. Bartfay WJ, Bartfay E. Systemic oxygen-free radical production in iron-loaded mice. West J Nurs Res 2000;22(8):927-935
8. Bartfay WJ, Hou D, Lehotay DC, et al. Cytotoxic aldehyde generation in heart following acute iron-loading. J Trace Elem Med Biol 2000;14(1):14-20
9. Bartfay WJ, Hou D, Lehotay DC, et al. Cytotoxic aldehyde generation in heart following acute iron-loading. J Trace Elem Med Biol 2000;14(1): 14-20
10. Davis MT, Bartfay WJ. Ebselen decreases oxygen free radical production and iron concentrations in the hearts of chronically iron-overloaded mice. Biol Res Nurs 2004;6(1):37-45
11. Drueke TB, Massy ZA. Intravenous iron: how much is too much? J Am Soc Nephrol 2005;16(10):2833-2835
12. Val Erio L G. Petersen DR. Characterization of hepatic iron overload following dietary administration of dicyclopentadienyl iron (Ferrocene) to mice: cellular, biochemical, and molecular aspects. Exp Mol Pathol 2000;68(1):1-12
13. Wang BY, Li YS, Huang GS. Pahtologic Technology. Beijing: People's Medical Publishing House 2000(6):206
14. Kontoghiorghes GI. Iron mobilization from transferrin and non-transferrin-bound-iron by deferiprone. Implications in the treatment of thalassemia, anemia of chronic disease, cancer and other conditions. Hemoglobin 2006;30(2):183-200
15. Bartfay WJ, Lehotay DC, Sher GD, et al. Erythropoiesis: Comparison of Cytotoxic Aldehyde Generation in Beta-Thalassemia Patients Chelated with Deferoxamine or Deferiprone (L1) Versus NO Chelation. Hematology 1999;4(1):67-76
16. Franchini M, Veneri D. Hereditary hemochromatosis. Hematology 2005;10(2):145-149
17. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13(4):399-408
18. Liu P, Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther 1994;8(1):101-110
19. Wheeler CJ, Kowdley KV. Hereditary hemochromatosis: a review of the genetics, mechanism, diagnosis, and treatment of iron overload. Compr Ther 2006;32(1):10-16
20. Zhang CH. Much Iron in Body and Heart Damage. Linchuang Huicui 1995,10(5):193-194
21. Berg D, Hochstrasser H. Iron metabolism in Parkinsonian syndromes. Mov Disord 2006;21(9):1299-1310
22. Zhou HY, Mao FY, Peng KL, et al. A Study of the Hepatotoxicity of Octyl-Ferrocene. Haijun Yixue Zazhi 2002,23(3):196-199
23. Ge KY. An Overview of Nutrition Sciences. Beijing: People's Medical Publishing House 2004:805-808
24. Huang HQ, Xiao ZQ, Chen X, et al. Characteristics of structure, composition, mass spectra, and iron release from the ferritin of shark liver (Sphyrna zygaena). Biophys Chem 2004;111(3):213-222
25. Valerio LG Jr, Petersen DR. Characterization of hepatic iron overload following dietary administration of dicyclopentadienyl iron (Ferrocene) to mice: cellular, biochemical, and molecular aspects. Exp Mol Pathol 2000;68(1):1-12
26. Tjalkens RB, Valerio LG Jr, Awasthi YC, et al. Association of glutathione S-transferase isozyme-specific induction and lipid peroxidation in two inbred strains of mice subjected to chronic dietary iron overload. Toxicol Appl Pharmacol 1998;151(1):174-181
27. Zhou HY. The research of hepatic damage with much iron. Haijun Yixue Zazhi 2001;22(4):358-362
28. Yurkova I, Kisel M, Arnhold J, et al. Iron-mediated free-radical formation of signaling lipids in a model system. Chem Phys Lipids 2005;137(1-2): 29-37
29. Knutson MD, Walter PB, Ames BN, et al. Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J Nutr 2000;130(3): 621-628
30. Parks RR, Huang CC, Haddad J Jr. Evidence of oxygen radical injury in experimental otitis media. Laryngoscope 1994;104(11 Pt 1):1389-1392